Discovery of a Dual Tubulin and Neuropilin‑1 (NRP1) Inhibitor with Potent In Vivo Anti-Tumor Activity via Pharmacophore-based Docking Screening, Structure Optimization, and Biological Evaluation
Article in Journal of Medicinal Chemistry (November 2023)